{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:14:56Z","timestamp":1794672896987,"version":"4.9.1"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>HIV\/AIDS remains a global health challenge with significant disparities in access to prevention strategies, particularly among underserved populations. Pre-exposure prophylaxis (PrEP) has proven to be an effective intervention in reducing HIV transmission, yet its uptake remains suboptimal in Europe. This report examines the current state of PrEP implementation in Spain, identifies key barriers to its access and proposes strategies for overcoming these obstacles, with a focus on equity and innovation. Despite PrEP being available since 2019, challenges such as centralized, hospital-based distribution, stigmatization, rigid eligibility criteria, excess medicalization and insufficient healthcare provider education persist. This study highlights the disproportionate underutilization of PrEP among populations with difficulty accessing prevention programmes, including women, migrants, sex workers, transgender individuals and people who inject drugs. Moreover, the introduction of long-acting injectables (LAI) and their endorsement by WHO represent a promising solution to improve PrEP efficacy, adherence and reduce the burden of frequent clinic visits. Drawing on successful international models, such as the 56 Dean Street clinic in London, this paper advocates for a decentralized, de-medicalized, community-based approach to PrEP delivery alongside policy reforms to simplify eligibility criteria and integrate PrEP into broader healthcare services. These solutions aim to address geographical and socio-cultural barriers, ultimately facilitating more equitable access to HIV prevention across Europe. The findings emphasize the importance of flexibility, community engagement and innovation to ensure that those most at need are ultimately offered PrEP, contributing to global efforts to close the HIV prevention gap.<\/jats:p>","DOI":"10.1093\/jac\/dkag052","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:41:37Z","timestamp":1769776897000},"source":"Crossref","is-referenced-by-count":6,"title":["Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populations"],"prefix":"10.1093","volume":"81","author":[{"given":"Josep M","family":"Llibre","sequence":"first","affiliation":[{"name":"Infectious Diseases Division, Fight Infections Foundation, University Hospital Germans Trias I Pujol , Barcelona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Epidemiologia y Salud P\u00fablica (CIBERESP) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Iniesta","sequence":"additional","affiliation":[{"name":"Spanish Interdisciplinary AIDS Society (SEISIDA) , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Tittle","sequence":"additional","affiliation":[{"name":"Chelsea and Westminster Hospital NHS Foundation Trust 56 Dean Street, , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Clement","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Louisiana State University Health Sciences Center , LA, New Orleans ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Rivero","sequence":"additional","affiliation":[{"name":"BCN Checkpoint\/Infectious Diseases Division, Fight Infections Foundation, University Hospital Germans Trias I Pujol , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Armenteros-Yeguas","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]},{"name":"Centro Sanitario Sandoval, Hospital Cl\u00ednico San Carlos\u2014Instituto de Investigaci\u00f3n Sanitaria San Carlos (IdISSC) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"\u00c1lvarez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Unitat ITS\/VIH Drassanes-Vall D\u2019Hebron, Hospital Universitari Vall D\u2019Hebron , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-7419","authenticated-orcid":false,"given":"Pablo","family":"Ryan","sequence":"additional","affiliation":[{"name":"Spanish Interdisciplinary AIDS Society (SEISIDA) , Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]},{"name":"Hospital Universitario Infanta Leonor, Department of Medicine, Faculty of Medicine, Complutense University of Madrid , Madrid ,","place":["Spain"]},{"name":"Grupo de Estudio de Infecciones de Transmisi\u00f3n Sexual (GEITS), Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9450","authenticated-orcid":false,"given":"Jos\u00e9 R","family":"Arribas","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]},{"name":"Servicio de Medicina Interna, Hospital Universitario La Paz\u2013IdiPAZ , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2843-1094","authenticated-orcid":false,"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[{"name":"Servicio de Enfermedades Infecciosas, Hospital Universitario Ram\u00f3n y Cajal\u2013IRYCIS, CIBERINFEC , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"2026022512413366700_dkag052-B1","author":"UNAIDS"},{"key":"2026022512413366700_dkag052-B2","author":"UnAIDS"},{"key":"2026022512413366700_dkag052-B3","author":"UNAIDS"},{"key":"2026022512413366700_dkag052-B4","author":"World Health Organization (WHO)"},{"key":"2026022512413366700_dkag052-B5","author":"European Center for Disease Prevention and Control (ECDC)"},{"key":"2026022512413366700_dkag052-B6"},{"key":"2026022512413366700_dkag052-B7","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2026022512413366700_dkag052-B8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"2026022512413366700_dkag052-B9","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S2352-3018(23)00079-6","article-title":"The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities","volume":"10","author":"Haberer","year":"2023","journal-title":"Lancet HIV"},{"key":"2026022512413366700_dkag052-B10"},{"key":"2026022512413366700_dkag052-B11","author":"Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13722-024-00478-2","article-title":"Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods","volume":"19","author":"Merle","year":"2024","journal-title":"Addict Sci Clin Pract"},{"key":"2026022512413366700_dkag052-B13","doi-asserted-by":"publisher","first-page":"e028768","DOI":"10.1136\/bmjopen-2018-028768","article-title":"Cohort profile: l'Actuel Pre-exposure prophylaxis (PrEP) cohort study in Montreal, Canada","volume":"9","author":"Greenwald","year":"2019","journal-title":"BMJ Open"},{"key":"2026022512413366700_dkag052-B14","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1016\/S2352-3018(23)00261-8","article-title":"Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial","volume":"10","author":"Landovitz","year":"2023","journal-title":"Lancet HIV"},{"key":"2026022512413366700_dkag052-B15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMoa2411858","article-title":"Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons","volume":"392","author":"Kelley","year":"2025","journal-title":"N Engl J Med"},{"key":"2026022512413366700_dkag052-B16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","article-title":"Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women","volume":"391","author":"Bekker","year":"2024","journal-title":"N Engl J Med"},{"key":"2026022512413366700_dkag052-B17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","author":"Delany-Moretlwe","year":"2022","journal-title":"Lancet"},{"key":"2026022512413366700_dkag052-B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"2026022512413366700_dkag052-B19","doi-asserted-by":"publisher","first-page":"100313","DOI":"10.1016\/j.focus.2025.100313","article-title":"Preference for long-acting injectable PrEP compared with daily oral PrEP among transgender women in the U.S.: findings from a multisite cohort","volume":"4","author":"Cooney","year":"2025","journal-title":"AJPM Focus"},{"key":"2026022512413366700_dkag052-B20","doi-asserted-by":"publisher","first-page":"23259582241293336","DOI":"10.1177\/23259582241293336","article-title":"Location preferences for accessing long-acting injectable Pre-exposure prophylaxis (LA-PrEP) among men who have sex with men (MSM) currently on daily oral PrEP","volume":"23","author":"Glick","year":"2024","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2026022512413366700_dkag052-B21","author":"World Health Organization (WHO)"},{"key":"2026022512413366700_dkag052-B22","author":"World Health Organization (WHO)"},{"key":"2026022512413366700_dkag052-B23","author":"Gilead Sciences"},{"key":"2026022512413366700_dkag052-B24","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2105\/AJPH.2019.305172","article-title":"Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States","volume":"109","author":"Siegler","year":"2019","journal-title":"Am J Public Health"},{"key":"2026022512413366700_dkag052-B25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1071\/SH18103","article-title":"Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and emerging models of PrEP implementation","volume":"15","author":"Sullivan","year":"2018","journal-title":"Sex Health"},{"key":"2026022512413366700_dkag052-B26","author":"European Medicines Agency (EMA)"},{"key":"2026022512413366700_dkag052-B27","author":"Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B28"},{"key":"2026022512413366700_dkag052-B29"},{"key":"2026022512413366700_dkag052-B30","doi-asserted-by":"publisher","first-page":"e0246129","DOI":"10.1371\/journal.pone.0246129","article-title":"Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models","volume":"16","author":"Iniesta","year":"2021","journal-title":"PLoS One"},{"key":"2026022512413366700_dkag052-B31","author":"Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B32","author":"European Center for Disease Prevention and Control (ECDC)"},{"key":"2026022512413366700_dkag052-B33","author":"Sociedad Espa\u00f1ola Interdisplinaria del SIDA (SEISIDA)"},{"key":"2026022512413366700_dkag052-B34","author":"Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B35","author":"Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B36","doi-asserted-by":"publisher","first-page":"503828","DOI":"10.1016\/j.anpede.2025.503828","article-title":"Increase in sexually transmitted infections in adolescents: an urgent challenge","volume":"102","author":"Navarro Gomez","year":"2025","journal-title":"An Pediatr (Engl Ed)"},{"key":"2026022512413366700_dkag052-B37","author":"Unidad de vigilancia de VIH ITS y hepatitis; Centro Nacional de Epidemiolog\u00eda; Instituto de Salud Carlos III\/Divisi\u00f3n de control de VIH I, Hepatitis virales y tuberculosis; Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/sextrans-2021-055277","article-title":"Complex PrEP: the factors requiring consultant-led review of PrEP users","volume":"98","author":"Tittle","year":"2022","journal-title":"Sex Transm Infect"},{"key":"2026022512413366700_dkag052-B39","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/S2352-3018(22)00364-2","article-title":"Nurse-led PrEP provision at 56 Dean Street","volume":"10","author":"Whitlock","year":"2023","journal-title":"Lancet HIV"},{"key":"2026022512413366700_dkag052-B40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/hiv.13149","article-title":"The success of HIV combination prevention: the Dean Street model","volume":"22","author":"Girometti","year":"2021","journal-title":"HIV Med"},{"key":"2026022512413366700_dkag052-B41","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1111\/hiv.70075","article-title":"HIV prevention in London, UK, from 2017 to 2024: outcomes, gaps and learnings","volume":"26","author":"Whitlock","year":"2025","journal-title":"HIV Med"},{"key":"2026022512413366700_dkag052-B42","author":"European Center for Disease Prevention and Control (ECDC)"},{"key":"2026022512413366700_dkag052-B43","doi-asserted-by":"publisher","first-page":"e0002851","DOI":"10.1371\/journal.pgph.0002851","article-title":"Barriers and facilitators to utilizing HIV prevention and treatment services among migrant youth globally: a scoping review","volume":"4","author":"Li","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"2026022512413366700_dkag052-B44","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/09564624211069236","article-title":"Social contextual factors associated with lifetime HIV testing among the Tushirikiane urban refugee youth cohort in Kampala, Uganda: cross-sectional findings","volume":"33","author":"Logie","year":"2022","journal-title":"Int J STD AIDS"},{"key":"2026022512413366700_dkag052-B45","author":"Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12961-024-01172-0","article-title":"Restrictive migration policies and their impact on HIV prevention, care and treatment services","volume":"22","author":"Ekerin","year":"2024","journal-title":"Health Res Policy Syst"},{"key":"2026022512413366700_dkag052-B47","author":"WHO Regional Office for Europe; European Centre for Disease Prevention and Control (ECDC)"},{"key":"2026022512413366700_dkag052-B48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.55633\/s3me\/039.2025","article-title":"Gender-based screening bias in HIV","volume":"37","author":"Robert Boter","year":"2025","journal-title":"Emergencias"},{"key":"2026022512413366700_dkag052-B49","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/hiv.13458","article-title":"PrEP for women in Europe: a systematic literature review","volume":"24","author":"Fitzgerald","year":"2023","journal-title":"HIV Med"},{"key":"2026022512413366700_dkag052-B50","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1016\/j.jve.2020.100026","article-title":"Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European region - results from a European survey study","volume":"7","author":"Moseholm","year":"2020","journal-title":"J Virus Erad"},{"key":"2026022512413366700_dkag052-B51","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S2352-3018(24)00300-X","article-title":"Event-driven PrEP beyond cisgender men who have sex with men","volume":"12","author":"Irie","year":"2025","journal-title":"Lancet HIV"},{"key":"2026022512413366700_dkag052-B52","doi-asserted-by":"publisher","first-page":"e0246037","DOI":"10.1371\/journal.pone.0246037","article-title":"\u201cYes, i'm interested in taking PrEP!\u201d: PrEP interest among women respondents to the European community-based survey \u201cflash! PrEP in Europe\u201d","volume":"16","author":"Delabre","year":"2021","journal-title":"PLoS One"},{"key":"2026022512413366700_dkag052-B53","doi-asserted-by":"publisher","first-page":"1221101","DOI":"10.3389\/frph.2023.1221101","article-title":"Safety surveillance for PrEP in pregnant and breastfeeding women","volume":"5","author":"Fairlie","year":"2023","journal-title":"Front Reprod Health"},{"key":"2026022512413366700_dkag052-B54","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1089\/aid.2013.0044","article-title":"Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue","volume":"29","author":"Louissaint","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2026022512413366700_dkag052-B55","author":"Federaci\u00f3n Estatal de Lesbianas Gais Trans Bisexuales Intersexuales y m\u00e1s (FELGTBI+)"},{"key":"2026022512413366700_dkag052-B56","author":"Sinc"},{"key":"2026022512413366700_dkag052-B57","author":"Infobae"},{"key":"2026022512413366700_dkag052-B58","author":"Ministerio de Sanidad"},{"key":"2026022512413366700_dkag052-B59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1089\/trgh.2022.0048","article-title":"Gender affirming hormones do not affect the exposure and efficacy of F\/TDF or F\/TAF for HIV preexposure prophylaxis: a subgroup analysis from the DISCOVER trial","volume":"9","author":"Cespedes","year":"2024","journal-title":"Transgend Health"},{"key":"2026022512413366700_dkag052-B60","author":"Ministerio de Igualdad"},{"key":"2026022512413366700_dkag052-B61","author":"UNAIDS"},{"key":"2026022512413366700_dkag052-B62","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s10508-024-02834-4","article-title":"Determinants of intention to use HIV Pre-exposure prophylaxis and condom use among a sample of cisgender female sex workers working mostly outdoors in Madrid, Spain","volume":"53","author":"Vazquez Guillamet","year":"2024","journal-title":"Arch Sex Behav"},{"key":"2026022512413366700_dkag052-B63","author":"Comit\u00e9 internacional de los derechos de las trabajadoras sexuales en Europa"},{"key":"2026022512413366700_dkag052-B64","author":"European Men-who-have-sex-with-men and trans people internet survey (EMIS)"},{"key":"2026022512413366700_dkag052-B65","doi-asserted-by":"publisher","first-page":"1391390","DOI":"10.3389\/fpubh.2024.1391390","article-title":"Descriptive study on substance uses and risk of sexually transmitted infections in the practice of chemsex in Spain","volume":"12","author":"Del Pozo-Herce","year":"2024","journal-title":"Front Public Health"},{"key":"2026022512413366700_dkag052-B66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.eimc.2016.06.006","article-title":"To whom is HIV pre-exposure prophylaxis proposed?","volume":"35","author":"Ayerdi-Aguirrebengoa","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2026022512413366700_dkag052-B67","doi-asserted-by":"publisher","first-page":"e0220272","DOI":"10.1371\/journal.pone.0220272","article-title":"Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): data from the U-SEX GESIDA 9416 study","volume":"14","author":"Dolengevich-Segal","year":"2019","journal-title":"PLoS One"},{"key":"2026022512413366700_dkag052-B68","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s11904-023-00667-9","article-title":"Integrated care models: HIV and substance use","volume":"20","author":"Hill","year":"2023","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026022512413366700_dkag052-B69","doi-asserted-by":"publisher","first-page":"104795","DOI":"10.1016\/j.drugpo.2025.104795","article-title":"A systematic review of intervention strategies aimed at chemsex users","volume":"140","author":"Incera-Fernandez","year":"2025","journal-title":"Int J Drug Policy"},{"key":"2026022512413366700_dkag052-B70","doi-asserted-by":"publisher","first-page":"e717","DOI":"10.1016\/S2352-3018(22)00124-2","article-title":"HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men","volume":"9","author":"Strong","year":"2022","journal-title":"Lancet HIV"},{"key":"2026022512413366700_dkag052-B71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13033-024-00629-7","article-title":"Factors associated with satisfaction and perceived helpfulness of mental healthcare: a world mental health surveys report","volume":"18","author":"Harris","year":"2024","journal-title":"Int J Ment Health Syst"},{"key":"2026022512413366700_dkag052-B72","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2468-2667(25)00062-3","article-title":"Effect of extending PrEP initiation to primary care settings: a nationwide cohort study in France","volume":"10","author":"Bamouni","year":"2025","journal-title":"Lancet Public Health"},{"key":"2026022512413366700_dkag052-B73","doi-asserted-by":"publisher","first-page":"e51023","DOI":"10.2196\/51023","article-title":"Online-mediated HIV Pre-exposure prophylaxis care and reduced monitoring frequency for men who have sex with men: protocol for a randomized controlled noninferiority trial (EZI-PrEP study)","volume":"12","author":"Groot Bruinderink","year":"2023","journal-title":"JMIR Res Protoc"},{"key":"2026022512413366700_dkag052-B74","author":"Groot Bruinderink"},{"key":"2026022512413366700_dkag052-B75","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eimce.2024.03.004","article-title":"Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users","volume":"42","author":"Ayerdi","year":"2024","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"2026022512413366700_dkag052-B76","author":"Department of Health & Social Care at gov.uk. Policy paper"},{"key":"2026022512413366700_dkag052-B77","doi-asserted-by":"publisher","first-page":"e073459","DOI":"10.1136\/bmjopen-2023-073459","article-title":"Feasibility and impact of online HIV\/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial","volume":"13","author":"Agusti","year":"2023","journal-title":"BMJ Open"},{"key":"2026022512413366700_dkag052-B78","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1016\/S2468-2667(22)00106-2","article-title":"Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study","volume":"7","author":"Jourdain","year":"2022","journal-title":"Lancet Public Health"},{"issue":"Suppl 2","key":"2026022512413366700_dkag052-B79","doi-asserted-by":"publisher","first-page":"e26107","DOI":"10.1002\/jia2.26107","article-title":"Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition","volume":"26","author":"Lorenzetti","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"2026022512413366700_dkag052-B80","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"2026022512413366700_dkag052-B81","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(22)00133-3","article-title":"Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study","volume":"9","author":"Molina","year":"2022","journal-title":"Lancet HIV"},{"key":"2026022512413366700_dkag052-B82","author":"EPI-PHARE (ANSM-CNAM)"},{"key":"2026022512413366700_dkag052-B83","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41746-025-01743-7","article-title":"Real-time digital intervention on oral pre-exposure prophylaxis adherence among MSM: randomized controlled trial","volume":"8","author":"Chu","year":"2025","journal-title":"NPJ Digit Med"},{"key":"2026022512413366700_dkag052-B84","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/hiv.70048","article-title":"Knowledge about biomedical HIV prevention among healthcare workers: a cross-sectional study in Europe and Central Asia","volume":"26","author":"Mendez-Lopez","year":"2025","journal-title":"HIV Med"},{"key":"2026022512413366700_dkag052-B85","author":"Ministerio de Sanidad"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/3\/dkag052\/66888072\/dkag052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/3\/dkag052\/66888072\/dkag052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:41:37Z","timestamp":1772041297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag052\/8482266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag052","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,2]]},"article-number":"dkag052"}}